Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Papp

Showing results (201-210 of 461) with videos related to

Pageof 47
Sort By:
Clinical Drug Investigation|October 12, 2010
Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life: analysis of pooled data from two randomized, double-blind, placebo-controlled, multicentre clinical trialsKim A Papp, James Signorovitch, Karthik Ramakrishnan, et al.
Cutis|December 2, 2024
Treat-to-Target Outcomes With Tapinarof Cream 1% in Phase 3 Trials for Plaque PsoriasisApril W Armstrong, Robert Bissonnette, Raj Chovatiya, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 17, 2015
[Erratum to: Accuracy and relevance of CT volumetry in open ocular injuries with intraocular foreign bodies]O A Maneschg, E Volek, Z Lohinai, et al.
Annales Chirurgiae Et Gynaecologiae|February 8, 2000
Histological evaluation of poly(L-lactide/epsilon-caprolactone) membrane implanted subcutaneously in ratsN Ashammakhi, A Papp, R Sayed, et al.
Journal of the American Academy of Dermatology|November 27, 2002
A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasisGerald G Krueger, Kim A Papp, Dow B Stough, et al.
Journal of Cutaneous Medicine and Surgery|April 25, 2006
Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approachesRichard G Langley, Vincent Ho, Charles Lynde, et al.
Veterinary Parasitology|March 21, 2016
Retrospective study on the distribution of Dirofilaria immitis in dogs in HungaryÁ Bacsadi, A Papp, L Szeredi, et al.
Annals of Biomedical Engineering|September 1, 1996
Computational simulations of mitral regurgitation quantification using the flow convergence method: comparison of hemispheric and hemielliptic formulaeJ Hopmeyer, E Whitney, D A Papp, et al.
Acta Biologica Hungarica|February 7, 2007
Immunotoxicological investigation of subacute combined exposure with low doses of Pb, Hg and Cd in ratsL Institóris, Dóra Kovács, I Kecskeméti-Kovács, et al.
American Journal of Clinical Dermatology|November 13, 2018
Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 StudiesApril W Armstrong, Kristian Reich, Peter Foley, et al.
Pageof 47

Showing results (201-210 of 461) with videos related to

Sort By:
Pageof 47
Clinical Drug Investigation|October 12, 2010
Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life: analysis of pooled data from two randomized, double-blind, placebo-controlled, multicentre clinical trialsKim A Papp, James Signorovitch, Karthik Ramakrishnan, et al.
Cutis|December 2, 2024
Treat-to-Target Outcomes With Tapinarof Cream 1% in Phase 3 Trials for Plaque PsoriasisApril W Armstrong, Robert Bissonnette, Raj Chovatiya, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 17, 2015
[Erratum to: Accuracy and relevance of CT volumetry in open ocular injuries with intraocular foreign bodies]O A Maneschg, E Volek, Z Lohinai, et al.
Annales Chirurgiae Et Gynaecologiae|February 8, 2000
Histological evaluation of poly(L-lactide/epsilon-caprolactone) membrane implanted subcutaneously in ratsN Ashammakhi, A Papp, R Sayed, et al.
Journal of the American Academy of Dermatology|November 27, 2002
A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasisGerald G Krueger, Kim A Papp, Dow B Stough, et al.
Journal of Cutaneous Medicine and Surgery|April 25, 2006
Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approachesRichard G Langley, Vincent Ho, Charles Lynde, et al.
Veterinary Parasitology|March 21, 2016
Retrospective study on the distribution of Dirofilaria immitis in dogs in HungaryÁ Bacsadi, A Papp, L Szeredi, et al.
Annals of Biomedical Engineering|September 1, 1996
Computational simulations of mitral regurgitation quantification using the flow convergence method: comparison of hemispheric and hemielliptic formulaeJ Hopmeyer, E Whitney, D A Papp, et al.
Acta Biologica Hungarica|February 7, 2007
Immunotoxicological investigation of subacute combined exposure with low doses of Pb, Hg and Cd in ratsL Institóris, Dóra Kovács, I Kecskeméti-Kovács, et al.
American Journal of Clinical Dermatology|November 13, 2018
Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 StudiesApril W Armstrong, Kristian Reich, Peter Foley, et al.
Pageof 47